Financial Life Planners Reduces Stake in Eli Lilly

Hedge fund cuts holding in pharmaceutical giant by over 85%

Mar. 11, 2026 at 8:52am

Got story updates? Submit your updates here. ›

Financial Life Planners, a hedge fund, has significantly reduced its stake in Eli Lilly and Company, one of the world's largest pharmaceutical companies. According to a recent SEC filing, the firm sold off over 1,000 shares of Eli Lilly stock, leaving it with just 175 shares worth $134,000 as of the end of the third quarter.

Why it matters

Eli Lilly is a major player in the pharmaceutical industry, known for its innovative drugs and therapies. The reduction in Financial Life Planners' position could signal a shift in investor sentiment or portfolio strategy, potentially impacting the stock's performance going forward.

The details

In its most recent 13F filing with the SEC, Financial Life Planners reported that it had sold 1,027 shares of Eli Lilly, reducing its total position by 85.4%. The firm now holds just 175 shares of the company's stock, valued at $134,000 as of the end of the third quarter.

Financial Life Planners made the stock sale during the 3rd quarter of 2026.

The players